Alio to Present in Upcoming Conferences

[vc_row][vc_column width=”1/1″][vc_column_text]BROOMFIELD, Colo., May 17, 2022 / — Alio™, a medical technology company reinventing the management of chronic disease and bringing peace of mind to people on dialysis, announced today David Kuraguntla, Chief Executive Officer, Rajesh Sivaprakasam, MD, FRCS, and Bart Dolmatch, MD, will be presenting in upcoming clinical-scientific conferences.

 

EuroPCR Meeting

May 17-20. 2022

Paris, France

Presentation: Innovators Day, Dave Kuraguntla, CEO, Alio, Thursday, 19 May 2022

https://www.pcronline.com/Courses/EuroPCR

 

Vascular Access for Hemodialysis Symposium / Vascular Access Society of the Americas / VASA 2022

June 9-11, 2022

Charleston, SC

Presentations: Innovation Session, Dave Kuraguntla, CEO, Alio, Thursday, 9 June 2022

Podium Presentation Wearables, Rajesh Sivaprakasam, MD, FRCS, Saturday, 11 June 2022

https://www.vasamd.org/events/2022-sponsor-exhibitor-opportunities

 

EVC – 25^th European Vascular Course

June 12-14, 2022

Maastricht, The Netherlands

Presentation: Wearables. Next Level of Surveillance? Bart Dolmatch, MD, Saturday, 25 June 2022

https://esvs.org/event/evc_2022/

 

About Alio

Alio, Inc. (Broomfield, CO), is a medical technology company developing SmartPatch™ technology and using artificial intelligence (AI) to monitor multiple chronic indications, including end stage kidney disease (ESKD) patients undergoing hemodialysis.  Alio is dedicated to the development of remote monitoring that provides actionable clinical data for a variety of conditions to better target interventions for improved outcomes and reduced hospitalizations.[/vc_column_text][/vc_column][/vc_row]